23andMe Goes Global In Its Data-Mining Efforts
By Megan Molteni,
Wired
| 05. 18. 2018
Yanny or Laurel—could the secret to which word you hear be in your DNA? It’s a notion someone pitched at 23andMe headquarters Thursday, during the consumer genetics outfit’s annual Genome Research Day. (Spoiler: The company is not going to roll out a survey to see if the latest meme has a genetic component.)
The event—a sort of cross between a science fair and a recruiting booth—attracted more than 100 researchers to the company’s candy cane–colored lunchroom for a day of talks, poster presentations, and most importantly, information sessions about how to work with 23andMe’s consumer data riches.
23andMe has amassed more than 4 million genetic profiles from customers who’ve consented to be studied, one of the biggest genetic research resources in the US. And because most of those people fill out lots of surveys, each genetic profile comes attached to about 300 phenotypic data points—like how many cigarettes you’ve smoked during your lifetime or if anyone in your family has ever been diagnosed with mild cognitive impairment.
And while the company has doubled in size over the last two years...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...